Market View 31st July, 2026

View on market: Volatility persists, eagerly searching for growth:

Global markets started the day on a positive note as investor confidence improved. Strong earnings from major technology companies increased optimism about artificial intelligence, leading to buying across Asian markets. Most key markets in the region traded higher, supported by renewed interest in technology stocks and a better overall market mood. The US market also recovered after the previous session’s weakness. Positive corporate earnings, especially from leading technology companies, lifted investor sentiment and supported gains across major indices. The focus on artificial intelligence continued to drive buying interest and helped markets move higher. The Indian market ended the session in positive territory. Both benchmark indices closed with gains as buying was seen in large-cap stocks. Reliance Industries and HDFC Bank were among the major contributors to the market’s rise. Overall, market sentiment remained positive, supported by strength in global equities and improving confidence in technology-led growth. Investors will continue to watch corporate earnings and global developments for further market direction.

Key Quarterly Results

20MICRONS, AADHARHFC, AARTIDRUGS, ABB, ABCAPITAL, AETHER, APTUS, ASTEC, AVL, AXISOL, BAJAJFINSV, BAJAJHLDNG, BLUEDART, CONCORDBIO, CORONA, DHAMPURSUG, DIXON, GAIL, GLENMARK, GMDCLTD, GUJARATPOLY, IOC, ITC, JINDWORLD, JLHL, KAJARIACER, KELENRG, KIRLOSBROS, LGBBROSLTD, MARUTI, NATIONALUM, PUNJABCHEM, RAYMONDLSL, SANGHVIMOV, SEJALLTD, SHADOWFAX, SHREECEM, SJVN, SMSPHARMA, STAR, SUNPHARMA, TAJGVK, THELEELA, URBANCO, VOLTAMP.

Economic Calendar:

• USD: S&P Global and ISM Manufacturing PMI Data on 03^rd August 2026.
• IND: Foreign Reserves Data on 31^st July 2026.
• USD: Import and Export Data on 04^th August 2026.
• IND: Monetary Policy on 05^th August 2026.

BROKERAGE RADAR:

CITI ON MGL:

Target ₹1400 Recommendation Accumulate, Performance amid supply challenges on account of the West Asia conflict is impressive, Volumes, too, were ahead of expectations, led by strong, CNG volume growth managed to offset the impact through price hikes across segments.

MACQUARIE ON SWIGGY:

Target ₹230 Recommendation Underperform, Slower growth; higher cash burn, Swiggy has outlined a path to adj EBITDA breakeven in Instamart, both timeline and trajectory are opaque, Also in the context of a just appointed CEO for Instamart and significant management change we consider this aspirational and not a base case.

JEFFERIES ON SYRMA SGS:

Target ₹1430 Earlier Target ₹1185 Recommendation Hold, Strong Qtr, but Stock Rally Factors it Too, Prudence Recommended Post Sharp Rally, Raise EPS by 12-13% and est FY27-29 EPS CAGR at +33%, Healthy operating leverage further helped EBITDA margin, In-line with Syrma’s May26 outlook (+30-35% growth in FY27).

CITI ON EXIDE:

Target ₹410 Recommendation Accumulate, Q1 Results Significantly Above Estimates, See healthy revenue growth across segments, Price-hikes and better mix helped offset the impact of higher commodity costs on gross margin, Healthy operating leverage further helped EBITDA margin.

International Markets:

U.S & Europe:

*As per 31^st July.

Asian markets:

Stocks strong on Chart:

Commodities & Currency:

FRIENDS & FRIENDS:

View on market: Volatility persists, eagerly searching for growth

News Updates:

Source: Moneycontrol, Bloomberg Quint, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited (Elite Wealth Limited is wholly owned subsidiary of InCred Capital Financial Services Limited) does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Vindhyachal Prasad, Elite Wealth Limited, vindhyachal@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

1. All of the views expressed in the report accurately reflect his or her personal views about any and all of

the subject securities or issuers; and

2. No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale. Legal

Entities Disclosures

Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

1. 1. 1. Reports
      2. EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
      3. EWL or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
      4. EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

1. Compensation
2. EWL  or its associates have not received any compensation from the subject company in the past twelve months;
3. EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
4. EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
5. EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
6. EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research
7. In respect of Public Appearances
8. EWL or its associates have not received any compensation from the subject company in the past twelve months;
9. The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL